Sánchez-Pérez Belinda, Ramia José M
Department of General, Digestive and Transplantation Surgery, University Regional Hospital, Málaga 29010, Málaga, Spain.
Department of Surgery, Hospital General Universitario Dr. Balmis, Alicante 03010, Spain.
World J Gastrointest Oncol. 2024 Feb 15;16(2):255-258. doi: 10.4251/wjgo.v16.i2.255.
Enhanced recovery after surgery (ERAS) programs have been widely applied in liver surgery since the publication of the first ERAS guidelines in 2016 and the new recommendations in 2022. Liver surgery is usually performed in oncological patients (liver metastasis, hepatocellular carcinoma, cholangiocarcinoma, ), but the real impact of liver surgery ERAS programs in oncological outcomes is not clearly defined. Theoretical advantages of ERAS programs are: ERAS decreases postoperative complication rates and has been demonstrated a clear relationship between complications and oncological outcomes; a better and faster postoperative recovery should let oncologic teams begin chemotherapeutic regimens on time; prehabilitation and nutrition actions before surgery should also improve the performance status of the patients receiving chemotherapy. So, ERAS could be another way to improve our oncological results. We will discuss the literature about liver surgery ERAS focusing on its oncological implications and future investigations projects.
自2016年首版加速康复外科（ERAS）指南及2022年新建议发布以来，ERAS方案已在肝脏手术中广泛应用。肝脏手术通常在肿瘤患者（肝转移、肝细胞癌、胆管癌等）中进行，但ERAS方案对肿瘤学结局的实际影响尚不清楚。ERAS方案的理论优势在于：ERAS可降低术后并发症发生率，且已证实并发症与肿瘤学结局之间存在明确关联；术后更好、更快的恢复应使肿瘤治疗团队能够按时开始化疗方案；术前的预康复和营养措施也应改善接受化疗患者的身体状况。因此，ERAS可能是改善我们肿瘤学治疗效果的另一种方式。我们将讨论关于肝脏手术ERAS的文献，重点关注其对肿瘤学的影响及未来的研究项目。
